TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer

Go back to TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 3,691,379       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 3,691,379       

Compugen Ltd (NASDAQ: CGEN) Delayed: 1.94 -0.02 (1.02%)
Previous Close $1.96    52 Week High $7.79 
Open $1.97    52 Week Low $4.32 
Day High $1.97    P/E N/A 
Day Low $1.89    EPS $-0.36 
Volume 148,021       

Compugen Ltd (NASDAQ: CGEN) Delayed: 1.94 -0.02 (1.02%)
Previous Close $1.96    52 Week High $7.79 
Open $1.97    52 Week Low $4.32 
Day High $1.97    P/E N/A 
Day Low $1.89    EPS $-0.36 
Volume 148,021       

Daiichi Sankyo Co Limited Sponsored ADR (AMEX: DSNKY) Delayed: 17.84 -0.27 (1.49%)
Previous Close $18.11    52 Week High $26.24 
Open $18.08    52 Week Low $18.86 
Day High $18.08    P/E N/A 
Day Low $17.77    EPS $0.00 
Volume 72,844